Please provide your email address to receive an email when new articles are posted on . Of the cases referred to me for management of dry eye, many turn out to be manifestations of nerve damage ...

Many clinicians acknowledge that herpes zoster (or shingles) is not something they would wish to have, but they also seem to believe it just comes and goes. This could explain the rather low rate of ...

"These data suggest that health benefits of RZV immunization may extend beyond the well-described prevention of herpes zoster and postherpetic neuralgia." HealthDay News — Two doses of recombinant ...

The incidence of herpes zoster and herpes zoster ophthalmicus increase after age 50, and both are associated with an increased risk of cardiovascular complications. For patients ages 50 and older, the ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Valacyclovir can be beneficial for treating multiple episodes of keratitis or iritis in patients with ...

More Americans are being diagnosed with eye complications of shingles, but older adults can call the shots on whether they are protected from the painful rash that can cost them their eyesight. Among ...

The first vaccine for shingles in the United States — Zostavax — was approved by the US Food and Drug Administration in 2006. The landmark study, published in the The New England Journal of Medicine ...

This case is quoted, p. 78, in Dr. H. F. Damon's little book on Neurosis of the Skin, thus: "Dr. Williams, of Boston, has observed a case of inflammation of the eye from zoster frontalis. The ...

Significant treatment benefits seen at 18 months; in addition, risk for experiencing subsequent end points lower with valacyclovir. HealthDay News — One year of valacyclovir is beneficial for patients ...

In adults aged 50 years or older, the 2-dose recombinant zoster vaccine is linked to reduced risk for HZO, acute myocardial infarction, and stroke. HealthDay News — Two doses of recombinant zoster ...